Improved Understanding of JAK2 Inhibition in Polycythemia Vera

July 9th 2025

Luspatercept’s Benefit in MDS: Dr Garcia-Manero on COMMANDS Trial

July 7th 2025

Dr Boland: Updates in GI Cancer From ASCO 2025

Luspatercept-aamt shows significant survival benefits and transfusion independence in lower-risk MDS, reshaping treatment standards in hematology.

July 3rd 2025

Studies Explore Control of Thrombotic Events in High-Risk PV

Discover groundbreaking advancements in GI cancer treatments from ASCO 2025, highlighting innovative therapies and improved patient outcomes.

Targeted Oncology Staff

July 2nd 2025

QUILT-88 Study: Promising Survival in Pancreatic Cancer

During a live event, Mojtaba Akhtari, MD, discussed trials studying patients with high-risk polycythemia vera.

July 1st 2025

Hochhaus on ASC4START and Asciminib’s Superior Tolerability in CML-CP

The QUILT-88 study reveals promising survival rates for advanced pancreatic cancer patients using a multimodal treatment approach, combining chemotherapy and immunotherapy.

June 23rd 2025

FDA Draft Guidance Illuminates MDS Drug Development Pathways

Related Content

July 9th 2025

Luspatercept’s Benefit in MDS: Dr Garcia-Manero on COMMANDS Trial

July 7th 2025

Dr Boland: Updates in GI Cancer From ASCO 2025

Luspatercept-aamt shows significant survival benefits and transfusion independence in lower-risk MDS, reshaping treatment standards in hematology.

July 3rd 2025

Studies Explore Control of Thrombotic Events in High-Risk PV

Discover groundbreaking advancements in GI cancer treatments from ASCO 2025, highlighting innovative therapies and improved patient outcomes.

Targeted Oncology Staff

July 2nd 2025

QUILT-88 Study: Promising Survival in Pancreatic Cancer

During a live event, Mojtaba Akhtari, MD, discussed trials studying patients with high-risk polycythemia vera.

July 1st 2025